This site is intended for health professionals only

Goldshield and Scottish government settle over claims


Scottish ministers and health boards have reached settlement with an international pharmaceutical company of their civil claims for alleged anti-competitive cartel conduct in connection with the supply of drugs to the UK’s NHS.

Goldshield Group Plc, Goldshield Pharmaceuticals Ltd and Forley Generics Ltd have agreed to pay £750,000 in compensation and to provide co-operation in connection with ongoing civil claims, against a number of other firms regarding alleged generic drug price-fixing arrangements.

Goldshield Group, Goldshield Pharmaceuticals and Forley Generics have made this agreement without admitting liability, and this follows a similar settlement already agreed with the Department of Health in England.

Scotland’s Cabinet Secretary for Health and Wellbeing, Nicola Sturgeon, said:

“I am delighted that we have managed to reach a settlement agreement with Goldshield. This is a satisfactory conclusion to our negotiations.”

The Chairman of Goldshield Group Plc, Keith Hellawell, said:

“We recognise the importance of building strong working relationships with our customers. We view the NHS as a valued customer and are therefore very pleased with today’s settlement.”

In February 2005, Scottish ministers and health boards lodged claims in the civil courts in England against a number of companies, in connection with forming alleged price-fixing cartels in respect of warfarin, ranitidine and penicillin-based drugs.

The Scottish Government

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine